A Phase I/II Study of Romidepsin in HIV-Infected Adults With Suppressed Viremia on Antiretroviral Therapy to Assess Safety, Tolerability, and Activation of HIV-1 Expression
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Romidepsin (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 16 Aug 2021 Results published in the Journal of Infectious Diseases
- 22 Dec 2020 Results published in the Journal of Infectious Diseases
- 07 Mar 2019 Results determining safety of multiple Romidepsin doses presented at the 26th Conference on Retroviruses and Opportunistic Infections.